Kosei Yasumoto

Identification of a tumour associated antigen in lung cancer patients with asbestos exposure.

Manabu Yasuda, Hidetaka Uramoto, H. Uramoto, 2010, Anticancer research.

Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro

Tetsuro Baba, K. Sugio, K. Yasumoto, 2007, Cancer science.

Expression of cytochrome P450 in non-small cell lung cancer.

Masaru Morita, Hidetaka Uramoto, M. Morita, 2008, Frontiers in bioscience : a journal and virtual library.

Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations

Koichi Yamazaki, Satoshi Morita, Masahiro Fukuoka, 2009, Clinical Cancer Research.

Significance of Immunohistochemical Expression of Estrogen Receptors α and β in Squamous Cell Carcinoma of the Esophagus

T. Oyama, K. Sugio, K. Yasumoto, 2007, Clinical Cancer Research.

Simultaneous Cellular and Humoral Immune Response against Mutated p53 in a Patient with Lung Cancer1

Manabu Yasuda, K. Sugio, K. Yasumoto, 2004, The Journal of Immunology.

Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.

T. Oyama, K. Sugio, K. Yasumoto, 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.

K. Sugio, K. Yasumoto, M. Takenoyama, 2005, Cancer research.